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A wide variety of chiral succinimides have been prepared in high
yields and enantioselectivities by an asymmetric conjugate addition 
of 1,3-dicarbonyl compounds to maleimides under very mild
reaction conditions using the bifunctional benzimidazole-derived 
organocatalyst 5f.  
Computational and NMR studies support the hydrogen-bonding 
activation role of the catalyst and the origin of the 
stereoselectivity of the process. 
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Introduction 
Cyclic imides play a vital role in polymer, biological, 
medicinal, and synthetic chemistry.[1] In particular, 
succinimides are important building blocks usually present in 
natural products and drugs, such as phensuximide,[2] 
ethosuximide,[3] and andrimid[4] (Figure 1). 
 
 
Figure 1. Succinimides in pharmaceuticals and drugs. 
 
 
Chiral succinimides are valuable synthetic intermediates[5] and 
structural motifs in molecules with interesting biological 
activities.[4,6] Among the different methodologies available for 
the synthesis of chiral α-substituted succinimides,[7] the 
asymmetric conjugate addition to maleimides[8] has emerged as 
a powerful tool for the synthetic chemist, specially using chiral 
organocatalysts.[9] Thus, very high enantioselectivities have 
been obtained in the conjugate addition of ketones,[10] 
aldehydes,[11] and a wide variety of activated methylenes and 
methines,[12] to N-substituted maleimides. Regarding activated 
nucleophiles, 1,3-diketones,[12a] malonates,[12c] β-
ketoesters,[12a,c,d] anthrones,[12b,g] oxindoles,[12f] α-
cyanoacetates,[12j,k] α-nitroacetates,[12l] α-isocyanoacetates,[12m] 
azlactones,[12i] pyrazolones,[12n] and  oxazolones,[12o] have been 
successfully used as Michel donors, typically employing 
bifunctional chiral Brønsted base/hydrogen bonding 
organocatalysts (Figure 2).[9f]  
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Figure 2. Chiral bifunctional Brønsted base/hydrogen 
bonding organocatalysts. 
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Very recently, the utility of chiral 2-aminobenzimidazoles as 
organocatalysts for the asymmetric conjugate addition to 
nitroolefins has been disclosed by our group[13] and others[14] 
which benefits from 2-aminobenzimidazole’s characteristic 
dual hydrogen-bonding catalysis.[15] Thus, catalyst 5b (Figure 
2), in which the distance between hydrogen atoms Ha and Hb is 
in between the reported distances for the highly 
enantioselective thiourea[16] and squarimide-derived 
organocatalysts,[17] is a very active and general catalyst for the 
enantioselective conjugate addition of malonates, β-ketoesters, 
and 1,3-diketones to a wide range of conjugated nitroalkanes in 
the presence of TFA as cocatalyst.[13] 
Regarding the addition to maleimides, we have recently 
demonstrated that the recyclable chiral 2-aminobenzimidazole 
catalyst 5f, efficiently catalyzes the direct conjugate addition of 
different 1,3-dicarbonyl compounds to maleimides to give the 
corresponding chiral (S)-succinimides with very high 
enantiocontrol.[18] For this process, we tentatively proposed a 
transition state model where the benzimidazole-derived 
organocatalyst 5f carried out a bifunctional activation of the 
nucleophile and the electrophile.[18]   
Herein, we report the full study on this reaction including 
detailed NMR mechanistic studies as well as DFT calculations 
in order to elucidate on the catalytic active species and the H-
bond network between catalyst, nucleophile and maleimide 
responsible for the observed reactivity and enantioselectivity. 
Results and Discussion 
The synthesis of catalysts 5a-e has been already 
described[18a] and involves, as a common initial step, a solvent-
free aromatic nucleophilic substitution of (1R,2R)-1,2-
diaminocyclohexane to 2-chlorobenzimidazole followed by the 
corresponding derivatization of the primary amine. C2-
symmetric catalysts 5f[18a] and 5g were prepared by a twofold 
aromatic substitution with 2-chlorobenzimidazole and 1-
methyl-2-chlorobenzimidazol, respectively. 
In our previous optimization study,[18,19] we demonstrated 
the superiority of dimeric catalyst 5f over benzimidazole-
derived catalysts 5a-e in the conjugate addition of different 1,3-
dicarbonyl compounds to maleimides. For instance, the 5f (10 
mol-%)-catalyzed conjugate addition of acetylacetone (0.3 
mmol) to maleimide (0.15 mmol) in the presence of TFA (10 
mol-%) as cocatalyst and toluene as solvent, led to succinimide 
6a in an excellent 94% yield and 97% ee (Figure 3). We also 
showed, that the use of hydrogen-bond forming solvents such 
as H2O or MeOH, led to a drastic decrease in 
stereoselectivity.[18] Accordingly, and in order to confirm the 
hydrogen bonding activation mode of catalyst 5f in this reaction, 
we initially studied the aptitude of catalyst 5g (Figure 2, R1 = 
R2 = Me) in the process under the previously optimized reaction 
conditions. As depicted in Figure 3, only an 11% yield of 
succinimide 6a was obtained in a lower 48% ee, confirming the 
importance of the presence of the secondary amine for the 
optimal hydrogen-bonding catalyst performance. 
 
Figure 3. Conjugate addition of acetylacetone to maleimide 
catalyzed by 5f and 5g. 
Further optimization of the reaction conditions employing 
organocatalyst 5f (Table 1) showed a slight decrease in the 
enantioselectivity of the process when the conjugate addition 
was performed at 0 ºC, affording 6a in a 94% ee (entry 2). With 
respect to the role of the acid cocatalyst TFA in the reaction, a 
significant decrease in the enantioselectivity of the reaction 
(51% ee) was detected in the absence of TFA (Table 1, entry 3).  
This result clearly evidenced the higher ability of the 
protonated catalyst for hydrogen-bonding activation. Notably, a 
complete deactivation of the catalyst was observed when using 
a twofold excess (20 mol-%) of cocatalyst (Table 1, entry 4). 
Also, dependence of the enantioselectivity of the process on 
catalyst loading was observed (Table 1, entries 5 and 6). Finally, 
further optimization of catalyst loading revealed that only 1 
mol-% of 5f/TFA was able to afford a highly efficient reaction 
though the enantioselectivity of the process slightly decreased 
to 93% (Table 1, entry 7).  
 
Table 1. Enantioselective conjugate addition of acetylacetone to maleimide 
catalyzed by chiral 2-aminobenzimidazole catalyst 5fa) 
Entry 5f 
(mol-%) 
TFA (mol-
%) 
T 
(ºC) 
Yield 
(%)b) 
ee 
(%)c) 
1 10 10 30 94 97 
2 10 10 0 95 94 
3 10 − 30 94 51 
4 10 20 30 <5 − 
5 30 30 30 85 87 
6 100 100 30 81 83 
7 1 1 30 96 93 
a) Reaction conditions: acetylacetone (0.3 mmol), maleimide (0.15 mmol), 
5f (10 mol-%, 0.015 mmol, 0.05 M), TFA (10 mol-%, 0.015 mmol), solvent 
(0.3 mL), r.t., 24 h. b) Isolated yield after flash chromatography. c) 
Determined by chiral HPLC [OD-H, hexane/iPrOH: 85/15, 1 mL/min].  
At high catalyst concentrations (Table 1, entries 5 and 6), 
product racemization due to thermodynamic control of the 
process was discharged, since the enantioselectivity of the 
reaction kept constant within the course of the experiment when 
a 0.1 M catalyst concentration was used in the conjugate 
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addition (Figure 4). This was also confirmed when succinimide 
6a (97% ee) was submitted to the optimal reaction conditions 
[5f (10 mol-%), TFA (10 mol-%), toluene, 30 ºC] in the 
presence of a different nucleophile such as 3-
acetyldihydrofuran-2(3H)-one, being compound 6a only 
detected in the crude reaction mixture (TLC and 1HNMR) with 
the same optical purity (Scheme 1). 
 
 
Figure 4. Ee versus time for the conjugate addition of 
acetylacetone to maleimide catalyzed by 5f/TFA. 
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Scheme 1. Racemization study with 6a. 
Additional studies on catalyst concentration were 
performed on the model reaction. The ee values obtained at 
different catalyst concentrations (Table 2) were fairly consistent 
with the diffusion coefficients (D) of 5f/TFA, strongly 
indicating that the degree of hydrogen-bonded self-association 
of bifunctional organocatalyst 5f/TFA in solution plays a 
crucial role in determining the enantioselectivity of the 
process.[20] 
Table 2. Diffusion coefficients of 5f/TFA (10 mol-%) at different 
concentrations versus enantioselectivities in the asymmetric addition of 
acetylacetone to maleimide. 
Entry 5f/TFA Conc. (molar) D/DTol a) ee (%)b) 
1 0.01 0.33 96 
2 0.05 0.31 97 
3 0.1 0.20 88 
a) Diffusion coefficients D (10-10 m2s-1) at room temperature for 
5f/TFA corrected with respect to the solvent (toluene-d8) at 
different molar (M) concentrations.  b) Determined by chiral 
HPLC [OD-H, hexane/iPrOH: 85/15, 1 mL/min]. 
Under the optimized reaction conditions (Table 1, entry 1), 
the generality of the conjugate addition reaction with respect to 
the nucleophile and the maleimide acceptor was then 
investigated. As depicted in Figure 5, the conjugate addition of 
acetylacetone to different N-alkyl- and N-aryl maleimides 
afforded the corresponding 1,4-adducts 6b-6g in good yields 
and excellent enantioselectivities. All the studied substrates 
afforded similar levels of ee than maleimide (95−97% ee). The 
5f-catalyzed conjugate addition reaction was also applicable to 
α-substituted 3-methylpentane-2,4-dione, which afforded after 
addition to N-phenylmaleimide compound 6h in a 50% yield 
and a high 91% ee. Regarding non-symmetrical β-diketones, 
the addition of 1-phenylbutane-1,3-dione to maleimide afforded 
compound 6i in a 97% yield as a 58/42 mixture of 
diastereomers, both of them obtained with excellent 
enantioselectivity. The addition of the cyclic 2-
acetylcyclopentanone to N-phenylmaleimide afforded 
compound 6j in a 93% yield as a 93/7 mixture of diastereomers, 
both of them obtained with very high enantioselectivity (Figure 
5). 
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Figure 5. Conjugate addition of 1,3-diketones to maleimides 
catalyzed by 5f. 
The optimized catalytic system proved to be effective for 
β-ketoesters as well, being the expected products formed in 
high yields, moderate to good diastereoselectivity, and very 
high levels of enantioselectivity (Figure 6). The synthesis of 
compounds 6j-6n resulted especially interesting, since 
evidenced the ability of the catalytic system to synthesize 
adjacent quaternary/tertiary stereogenic centres with excellent 
enantioselectivities. 
We finished the nucleophile scope with malonates. 
Interestingly, catalyst 5f performed better in the absence of 
TFA for these nucleophiles. Then, when dimethyl malonate 
reacted, under the optimized reaction condition with maleimide, 
compound 6o was obtained in an 81% ee and a very low 23% 
isolated yield (Figure 6). This was probably due to the lower 
acidity of the nucleophile compared to 1,3-diketones and β-
ketoesters, thus requiring a catalyst with an stronger basic 
character. This was confirmed by performing the reaction in the 
absence of TFA, which afforded compound 6o in a 78% ee and 
a higher 74% isolated yield. With respect to yield, a similar 
tendency was observed in the reaction with N-methyl and N-
phenyl maleimides which afforded compounds 6p and 6q, in 
99% ee and high yields in the absence of TFA (Figure 6). 
Submitted to the European Journal of Organic Chemistry 4
 
Figure 6. Conjugate addition of β-ketoesters and dimethyl 
malonate to maleimides catalyzed by 5f. 
The synthetic utility of the catalytic methodology was 
confirmed by gram-scale experiments (5-20 mmol of Michael 
acceptor) for the synthesis of succinimides 6a, 6d, 6g, and 6k 
which were obtained as optically pure compounds (>99% ee) in 
high yields after filtration from the crude reaction mixture 
(Figure 7).[21] 
 
 
Figure 7. Gram-scale synthesis of chiral succinimides 6.  
 
 
 
The functional characteristics of the synthesized chiral 
1,3-dicarbonyl compounds 6 was used for the synthesis of 
optically active pyrazol-derived succinimides.[22] Thus, 
compounds 6a (97% ee) and 6e (97% ee) were transformed in 
succinimides 7a (99% ee) and 7e (99% ee) by treatment with 
N-phenylhidrazine in the presence of phosphotungstic acid as 
catalyst (1 mol-%) in water at r.t.  (Scheme 2). 
 
Scheme 2. Synthesis of chiral pyrazol-derived succinimides 7. 
DFT computational studies[23] were conducted aimed at 
detailing the H-bond network between catalyst, nucleophile and 
maleimide responsible for the observed 
reactivity/enantioselectivity. It was assumed that the reaction is 
initiated with the deprotonation of the pronuclephile (2,5-
pentadione) by the aminobenzimidazole catalyst to form an 
enolate/protonated catalyst binary complex (Figure 8). Further 
hydrogen bonding with the maleimide renders a ternary 
complex that evolves to the final products through the 
corresponding transition state. We found that the minimum 
Gibbs Free energy along the reaction coordinate always 
corresponded to the sum of the energies of the free maleimide 
and the binary complex, which was thus taken as the ground G 
= 0 energy level. 
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Figure 8. Main structures proposed along the reaction 
coordinate. 
 
Three possible mechanistic scenarios were considered: a) 
in the absence of acid, the basic catalyst deprotonates and binds 
the nucleophile (A, Figure 9). Four NH groups are available for 
Nu/maleimide activation, arranged in a flexible and open 
reactive site; b) if partial protonation (1 equiv of acid) of the 
catalyst is considered, the neutral portion of the catalyst 
deprotonates the nucleophile leading to structure B, which 
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possesses a tighter reactive space decorated with 3 or 4 NH 
groups for reagent activation; c) further protonation of the 
catalyst with a second molecule of acid would cancel the 
basicity of the catalyst, and only the enol form of the 
nucleophile could act as a nucleophile, like in structure C, 
lowering its reactivity. 
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Figure 9. Computed mechanistic alternatives A, B, and C. 
 
After an extensive conformational search, the calculated 
energies for the optimal transition states in model A predict a 
high reactivity and a moderate selectivity (1.7 kcal/mol energy 
difference between TSA2(S) and TSA2(R), Figure 10), which is 
in fair agreement with the experimental results in the absence of 
acid (94% yield, 51% ee, Table 1, entry 4). The privileged 
transition structures for each enantiomer (TSA2(S) and TSA2(R)) 
bear an intramolecular H bond between the protonated and the 
neutral benzimidazole portions of the catalyst. As a 
consequence, a quite open reaction space is formed, in which 
the remaining four NH bonds are involved in a low-selective 
binding of the nucleophile and electrophile (see 3D picture for 
TSA2(S) in Figure 10). 
In contrast, the inclusion of one molecule of 
trifluoroacetic acid might produce a fast protonation of the 
catalyst (model B). The CF3COO− anion is able to bind the two 
imidazole units, eliminating the possibility of an intramolecular 
H-bonding between them. The optimal transition structures 
were found, in which three of the NH groups are exposed to the 
trifluoroacetate anion and solvent. In this structure, the 
activation of the maleimide is achieved by a single NH bond, 
and two other NH groups bind the nucleophile, [24] in a tight, 
concave reaction site. This effect increases the energy 
difference between the diastereomeric forms TSB(S) and TSB(R) 
(24.7 and 29.3 kcal/mol respectively), predicting a high 
reactivity and very good enantioselectivity, as experimentally 
found (94% yield, 97% ee, Table 1, entry 1).  
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Figure 10. Main transition structures computed in models A 
and B 
 
As mentioned previously, the inclusion of a second 
molecule of TFA acid in the calculation has a deleterious effect 
on the reactivity of the catalyst (<5% conversion, Table 1, entry 
4). We also offer an explanation for this effect: The double 
protonation of the catalyst cancels its basic character and 
prevents the deprotonation of the nucleophile. Only the enol 
form of the nucleophile is available for the attack to the 
maleimide, and both enol and maleimide appear single bonded 
to the catalyst, as in model C. In this unfavourable scenario it is 
not surprising to find a high computed activation energy (46.3 
kcal/mol). 
 
Finally, the distinct outcome shown by the malonates as 
nucleophiles might be related to the lower basicity of dimethyl 
malonate vs acetylacetone (pKa´s in DMSO are 15.7 and 13.3 
respectively). In fact, the deprotonation of dimethyl malonate 
by the TFA-protonated catalyst (mechanism B) is computed to 
be a disfavoured process (Figure 11). Thus, both reactions of 
malonate in the presence or absence of TFA proceed through 
mechanism A, with a computed 86% ee, in fair agreement with 
the experimental 74-78% ee (Figue 6), and at different rates, 
since the acid exerts the negative effect of lowering the 
available amount of the necessary free imidazole.   
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Figure 11. Different binding properties of the computed 
nucleophiles. 
 
In summary, we have designed a chiral 2-
aminobenzimidazole catalyst 5f, which catalyzes the direct 
conjugate addition of different 1,3-dicarbonyl compounds to 
maleimide and N-substituted maleimides to give the 
corresponding Michael adducts in very high enantiocontrol. 
The proposed hydrogen-bonding activation role of the catalyst 
and the origin of the stereoselectivity of the process have been 
confirmed by DFT calculations. Further studies are in progress 
to explore the scope of organocatalyst 5f in other catalytic 
asymmetric reactions. 
Experimental Section 
To a stirred solution of catalyst 5f (5.2 mg, 0.015 mmol, 10 
mol-%) and maleimide (14.6 mg, 0.15 mmol) in toluene (185 µL), 
a 1% (v/v) TFA solution in toluene (115 μL, 0.015 mmol) and 
acetylacetone (30.8 µL, 0.3 mmol) were added. The reaction 
mixture was stirred at 30 ºC for 24 h. Then, the solvent was 
evaporated under reduced pressure to give the crude product which 
was purified by flash chromatography (EtOAc/hexane) to afford 
27.8 mg of pure 6a (94% yield). The selectivity of the reaction was 
determined by chiral HPLC before purification to be 97% ee 
(Chiralcel OD-H, 1 mL/min, Hexane/iPrOH: 85/15, λ 210 nm), 
tRmay = 28.5 min, tRmin = 33.4 min. 
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 Chiral Succinimides 
The chiral 2-aminobenzimidazole-
derived catalyst 5f serves as very 
efficient and selective bifunctional 
organocatalyst in the asymmetric 
conjugate addition of 1,3-dicarbonyl 
compounds to maleimide and N-
substituted maleimides. Computational 
and NMR studies support the hydrogen-
bonding activation role of the catalyst 
and the origin of the stereoselectivity of 
the process. 
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